BackNAYA Biosciences Common Stock Overview

NAYA Biosciences Common Stock Operating Income

Operating Income for IVF.

Quarterly Operating Income

$14.50B
↓ 278.49% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-7237356000.00
↓ 10.93% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin